Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$11.20M
147.82K shares
What this filing means
ZANTE GREG plans to sell 147.82K shares of VIKING THERAPEUTICS, INC. valued at approximately $11.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/28/2024ACC: 0001950047-24-007913
Officer· Chief Financial Officer
Since Jan 2021
147.82K
Shares to sell
$11.20M
Approx. market value
131.69K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Exercise of Stock Options
Cash
10/28/2024
94KEmployee Stock Purchase Plan
Cash
5/20/2024
11.05KRestricted Stock Units
N/A
3/28/2024
15.06KRestricted Stock Units
N/A
3/4/2024
11.57KTotal acquired131.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/28/2024 | Exercise of Stock Options Cash | 94K | — |
5/20/2024 | Employee Stock Purchase Plan Cash | 11.05K | — |
3/28/2024 | Restricted Stock Units N/A | 15.06K | — |
3/4/2024 | Restricted Stock Units N/A | 11.57K | — |
| Total | 131.69K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.14K
Market value
$922.2K
7/30/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
131.69K
Market value
$10.28M
10/28/2024
Total
Units
147.82K
Value
$11.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/30/2024 | 16.14K | $922.2K | — | Completed |
| Planned — Approximate Date | ||||
10/28/2024 | 131.69K | $10.28M | NASDAQ | Planned |
| Total | 147.82K | $11.20M | ||